{"database": "lobbying", "table": "lobbying_activities", "rows": [[2179862, "de46b743-3089-4a28-a772-775eab88ba4f", "Q3", "AMERICAN CAPITOL GROUP", 305852, "CHIMERIX, INC.", 2018, "third_quarter", "HCR", "Congressional Outreach regarding biodefense medical countermeasures for small pox, BARDA and FDA Related issues.", "HOUSE OF REPRESENTATIVES,SENATE", 15000, null, 0, 0, "2018-10-03T16:14:01.740000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["2179862"], "units": {}, "query_ms": 0.3275249619036913, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}